Teva Picks Vigodman as CEO Amid Restructuring

Teva Picks Vigodman as CEO Amid Restructuring Play

Jan. 9 (Bloomberg) -- Teva Pharmaceutical chose board member Erez Vigodman as chief executive officer of the world’s biggest generic-drug maker after the previous CEO left in a dispute with the board. Elliott Gotkine has more on Bloomberg Television's "Countdown." (Source: Bloomberg)

  • On Air Now

    Puerto Rico: Island of Debt and Opportunity Watch Now

  • Next

    Bloomberg West

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus